/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Larimar Therapeutics Inc Share Price Today: Live Updates & Key Insights

Larimar Therapeutics Inc share price today is $4.56, up 0.45%. The stock opened at $4.545 against the previous close of $4.47, with an intraday high of $4.92 and low of $4.42.

Larimar Therapeutics Inc Share Price Chart

style
pb-0

Larimar Therapeutics Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Larimar Therapeutics Inc Share Price Performance

$4.56 0.0045(0.45%) LRMR at 23 Mar 2026 02:01 PM Biotechnology
Lowest Today 4.42
Highest Today 4.92
Today’s Open 4.545
Prev. Close 4.47
52 Week High 6.42
52 Week Low 1.61
Day’s Range: Low 4.42 High 4.92
52-Week Range: Low 1.61 High 6.42
1 day return -
1 Week return +2.38
1 month return +60.03
3 month return +12.48
6 month return +0.67
1 year return +98.02
3 year return +4.04
5 year return -74.22
10 year return -

Larimar Therapeutics Inc Institutional Holdings

Deerfield Management Co 29.55

Blue Owl Capital Holdings LP 6.59

Millennium Management LLC 5.03

BlackRock Inc 3.22

RTW INVESTMENTS, LLC 3.02

Vanguard Group Inc 2.94

AIGH Capital Management, LLC 1.93

Vanguard Total Stock Mkt Idx Inv 1.88

The Goldman Sachs Group Inc 1.52

Citadel Advisors Llc 1.32

Point72 Asset Management, L.P. 1.18

iShares Russell 2000 ETF 1.17

Geode Capital Management, LLC 1.06

Dafna Capital Management LLC 0.91

Alyeska Investment Group, L.P. 0.90

State Street Corp 0.86

Woodline Partners LP 0.77

Jane Street Group LLC 0.66

Verition Fund Managegment, LLC 0.55

Driehaus Capital Management LLC 0.52

AQR Capital Management LLC 0.48

Fidelity Small Cap Index 0.46

Vanguard Institutional Extnd Mkt Idx Tr 0.44

Mangrove Partners 0.43

iShares Russell 2000 Value ETF 0.42

iShares Biotechnology ETF 0.34

Federated Hermes MDT SCC Institutional 0.30

Federated Hermes MDT Small Cap Core IS 0.30

State St Russell Sm/Mid Cp® Indx SL Cl I 0.26

Dimensional US Small Cap ETF 0.23

Vanguard Russell 2000 ETF 0.22

Fidelity Extended Market Index 0.21

Goldman Sachs Small Cp Val Insghts Instl 0.20

State St Russell Sm Cap® Indx SL Cl I 0.13

iShares Micro-Cap ETF 0.12

Schwab Small Cap Index 0.12

NT R2000 Index Fund - NL 0.10

Bridgeway Ultra-Small Company Market 0.10

Goldman Sachs Small Cap Eq Insghts Instl 0.09

Blackrock Extended Mkt Fund CF 0.08

Larimar Therapeutics Inc Market Status

Strong Buy: 10

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Larimar Therapeutics Inc Fundamentals

Market Cap 465.12 M

PB Ratio 3.3304

PE Ratio 0.0

Enterprise Value 291.96 M

Total Assets 145.84 M

Volume 2844320

Larimar Therapeutics Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-33381000 -33.4M, FY22:-34184000 -34.2M, FY21:-50310000 -50.3M, FY20:-42327000 -42.3M, FY19:-23132000 -23.1M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-87000 -0.1M, Q1/2025:-88000 -0.1M, Q3/2024:-74000 -0.1M, Q2/2024:-87000 -0.1M

Quarterly Net worth Q3/2025:-47712000 -47.7M, Q2/2025:-26182000 -26.2M, Q1/2025:-29281000 -29.3M, Q3/2024:-15499000 -15.5M, Q2/2024:-21627000 -21.6M

About Larimar Therapeutics Inc & investment objective

Company Information Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.

Organisation Biotechnology

Employees 71

Industry Biotechnology

CEO Dr. Carole S. Ben-Maimon M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Larimar Therapeutics Inc FAQs

What is the share price of Larimar Therapeutics Inc today?

The current share price of Larimar Therapeutics Inc is $4.56.

Can I buy Larimar Therapeutics Inc shares in India?

Yes, Indian investors can buy Larimar Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Larimar Therapeutics Inc shares in India?

You can easily invest in Larimar Therapeutics Inc shares from India by:

Can I buy fractional shares of Larimar Therapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Larimar Therapeutics Inc?

Larimar Therapeutics Inc has a market cap of $465.12 M.

In which sector does Larimar Therapeutics Inc belong?

Larimar Therapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in Larimar Therapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Larimar Therapeutics Inc?

The PE ratio of Larimar Therapeutics Inc is N/A and the PB ratio is 3.33.